INTERNATIONAL PATENT: PROTAGONIST THERAPEUTICS, INC., YANG, BO, BOURNE, GREGORY THOMAS, BHANDARI, ASHOK, TARANATH, ROOPA, HALLADAY, JASON FILES APPLICATION FOR "MONO- AND DUAL-AGONIST COMPOUNDS OF HUMAN GLP1R AND GIPR FOR OBESITY & T2DM"

Posted On: 2025-11-05

GENEVA, Nov. 5 -- PROTAGONIST THERAPEUTICS, INC. (7707 Gateway BoulevardSuite 140Newark, California 94560), YANG, Bo (c/o Protagonist Therapeutics, Inc.7707 Gateway BoulevardSuite 140Newark, California 94560), BOURNE, Gregory Thomas (c/o Protagonist Pty Ltd306 Carmody RoadSt. LuciaBrisbane, Queensland 4072), BHANDARI, Ashok (c/o Protagonist Therapeutics, Inc.7707 Gateway BoulevardSuite 140Newark, California 94560), TARANATH, Roopa (c/o Protagonist Therapeutics, Inc.7707 Gateway BoulevardSuite 140Newark, California 94560), HALLADAY, Jason (c/o Protagonist Therapeutics, Inc.7707 Gateway BoulevardSuite 140Newark, California 94560) filed a patent application (PCT/US2025/025105) for "MONO- AND DUAL-AGONIST COMPOUNDS OF HUMAN GLP1R AND GIPR FOR O...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: PROTAGONIST THERAPEUTICS, INC., YANG, BO, BOURNE, GREGORY THOMAS, BHANDARI, ASHOK, TARANATH, ROOPA, HALLADAY, JASON FILES APPLICATION FOR "MONO- AND DUAL-AGONIST COMPOUNDS OF HUMAN GLP1R AND GIPR FOR OBESITY & T2DM"